ArticleThe Journal of clinical investigation2001
Integrin-associated protein (CD47): an unusual activator of G protein signaling.
Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation.Molecular medicine (Cambridge, Mass.) · 2026Review
- CD47 Promotes, While Exposure to Apoptotic Cells Destroys the Fusion Program of Differentiating Myoblasts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
- Cannabidiol Regulates CD47 Expression and Apoptosis in Jurkat Leukemic Cells Dependent upon VDAC-1 Oligomerization.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer.Nature immunology · 2025Article
- Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside.Molecular cancer · 2025Review
- CD47: an immunoregulatory nexus in liver and gastrointestinal disorders.eGastroenterology · 2025Review
- Therapeutic potential for P2YPurinergic signalling · 2023Review
- Ferritin-based nanomedicine for disease treatment.Medical review (2021) · 2023Review
- A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy.Journal of nanobiotechnology · 2021Article
- Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine.International journal of molecular sciences · 2021Review
- Role of CD47 in Hematological Malignancies.Journal of hematology & oncology · 2020Review
- The PABPC5/HCG15/ZNF331 Feedback Loop Regulates Vasculogenic Mimicry of Glioma via STAU1-Mediated mRNA Decay.Molecular therapy oncolytics · 2020Article
- Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.Acta pharmaceutica Sinica. B · 2019Review
- CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.Matrix biology : journal of the International Society for Matrix Biology · 2014Article
- BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton.Cell death & disease · 2014Article
- Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis.Electrophoresis · 2012Article
- Article
- Continuous engagement of a self-specific activation receptor induces NK cell tolerance.The Journal of experimental medicine · 2008Article
- Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.Springer seminars in immunopathology · 2004Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.